Explore the Australian Prescriber issue: Volume 49 Issue 1.

This February issue features an editorial and an article about psychotropic medicines in people with cognitive disability or impairment. Other articles address pharmacological management of ADHD in adults; a critical appraisal of intra-articular hyaluronic acid injections for symptomatic osteoarthritis; managing infection risk associated with immunosuppressive therapies; and secondary prevention of acute coronary syndromes. The new drugs discuss Ivosidenib for cholangiocarcinoma and acute myeloid leukaemia and Vutrisiran for hereditary transthyretin-mediated amyloidosis.

The Australian Prescriber Podcast is an easy way to stay in the know, as it dives into some of the many great articles that Australian Prescriber features every two months. Listen to recent episodes on Testing for human immunodeficiency virus and Top 10 drugs 2024-25.